MedTrace Logo

National Prevalence and Impact of Noninvasive Prenatal Testing

NCT02284399 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4488

Last updated 2019-06-19

Study results available
· View outcomes & findings →

Summary

Information on pregnant women undergoing non-invasive prenatal testing (NIPT) at one of the Obstetrix Medical Groups Outpatient Centers between January 2012 and June 2014 will be retrospectively gathered and an analysis of the impact and prevalence of NIPT. This will be compared to a control group of pregnant women in those same practices undergoing prenatal testing during the months of January 2010-July 2010.

Conditions

  • Aneuploidy

Interventions

OTHER

non-invasive prenatal testing

Noninvasive Prenatal Testing (NIPT) of fetal cell free DNA in maternal circulation

Sponsors & Collaborators

  • Obstetrix Medical Group

    lead INDUSTRY

Principal Investigators

  • Kimberly Maurel, MSN · Mednax Inc.

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-06-28
Completion
2016-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02284399 on ClinicalTrials.gov